Torstein Baade Rø

Torstein Baade Rø serves as Professor and Vice-Dean of Research at the Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU). His dual role encompasses administrative leadership in research strategy and active contributions to pediatric oncology and endocrinology.

His educational background includes an MD (1996) and PhD (2006) from NTNU, followed by specialist certification in pediatrics (2008). Teaching responsibilities span general pediatrics, pediatric endocrinology, and adolescent medicine.

Rø's research program integrates basic and clinical investigations with two primary foci: First, molecular mechanisms in B-cell malignancies (multiple myeloma, lymphoma, leukemia), particularly the phosphatase PRL-3's role in cancer metabolism and signaling. Second, clinical diabetes research examining impaired hypoglycemia awareness in pediatric type 1 diabetes populations through the Norwegian Childhood Diabetes Registry. His work demonstrates consistent translational bridging between laboratory discoveries and patient-centered outcomes.

Analysis of his 15 most recent publications reveals a strategic dual-track approach: approximately 60% focus on neurorehabilitation in pediatric acquired brain injury (executive function training, fatigue management, school reintegration), while 40% investigate cancer biology (PRL-3 signaling, myeloma metabolism) and diabetes complications. This reflects deliberate expansion from his original cancer specialization into complementary pediatric chronic condition domains.

Rø actively supervises research through collaborative projects evidenced by frequent co-authorship with junior researchers on randomized controlled trials and mechanistic studies. His work leverages major institutional resources including the Norwegian Childhood Diabetes Registry and multi-center rehabilitation trials infrastructure.

His laboratory work centers on phosphatase signaling in B-cell cancers, while clinical teams focus on pediatric neurorehabilitation protocols and diabetes complication management. Current projects emphasize longitudinal follow-up methodologies and cross-disciplinary integration of neuropsychological and metabolic outcomes.